Product Description
Overall, the global carotid shunt market was valued at $119 million in 2023. This is expected to increase over the forecast period at a CAGR of 3.1% to reach $147 million.
Throughout this medical market research, we analyzed over 5 carotid shunt companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global market for carotid shunts extends its projections up to the year 2030, thereby providing a comprehensive and anticipatory understanding of the market trends and trajectories for the given period.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Carotid Shunt Market Insights

The carotid shunt market is witnessing a new trend marked by a rising acceptance of minimally invasive techniques and advancements in technology. Both physicians and patients are increasingly favoring less intrusive methods like Carotid Artery Stenting. This shift is motivated by the potential advantages, including shorter hospital stays, faster recovery, and decreased risks when compared to conventional surgical approaches like carotid endarterectomy.
Global Carotid Shunt Market Share Insights

- In 2023, LeMaitre Vascular emerged as the leader in the worldwide carotid shunt market, offering products under the Pruitt F3® and Flexcel® lines. LeMaitre Vascular‘s shunt portfolio is available globally and is promoted through direct sales teams in the U.S., Canada, Europe, New Zealand, Australia, Japan, and China. The company has also extended its reach through distribution partnerships in Brazil, South Africa, Turkey, Saudi Arabia, Russia, Thailand, Vietnam, Korea, and Taiwan.
- Securing the second position in the global carotid shunt market in 2023, Integra LifeSciences showcased its Integra® Sundt Carotid Endarterectomy Shunt portfolio, which includes configurations like non-reinforced internal straight, reinforced internal straight, reinforced external loop, and non-reinforced external loop shunts.
- In 2023, Becton Dickinson captured a modest share of the global carotid shunt market. The company’s carotid shunt offerings include various models, such as the Bard® Carotid Bypass Shunt (Straight), Bard® Javid™ Carotid Bypass Shunt, Bard® Brener™ Carotid Bypass Shunt, and Bard® Burbank™ Carotid Bypass Shunt.
Market Segmentation Summary
- Carotid Shunt Market
Global Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2023 |
| Forecast | 2024-2030 |
| Historical Data | 2020-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.